ES2159047T3 - Compuestos triciclicos. - Google Patents

Compuestos triciclicos.

Info

Publication number
ES2159047T3
ES2159047T3 ES96935342T ES96935342T ES2159047T3 ES 2159047 T3 ES2159047 T3 ES 2159047T3 ES 96935342 T ES96935342 T ES 96935342T ES 96935342 T ES96935342 T ES 96935342T ES 2159047 T3 ES2159047 T3 ES 2159047T3
Authority
ES
Spain
Prior art keywords
sup
similar
groups
tricycle
tricycle compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96935342T
Other languages
English (en)
Inventor
Makoto Yoshida
Shin-Ichi Sasaki
Shigeru Aono
Shigeki Fujiwara
Haruki Takai
Tsuyoshi Yamagata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Application granted granted Critical
Publication of ES2159047T3 publication Critical patent/ES2159047T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/16—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/12—[b,e]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C07D333/80—Seven-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02—Seven-membered rings
    • C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D337/12—[b,e]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/16—Benz[e]indenes; Hydrogenated benz[e]indenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/30—Ortho- or ortho- and peri-condensed systems containing three rings containing seven-membered rings
    • C07C2603/32—Dibenzocycloheptenes; Hydrogenated dibenzocycloheptenes

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPUESTOS TRICICLICOS REPRESENTADOS POR LA FORMULA GENERAL (I), QUE SON UTILES COMO AGENTES TERAPEUTICOS PARA LA INCONTINENCIA URINARIA: DONDE R{SUP,1} REPRESENTA HIDROGENO Y SIMILARES; - X{SUP,1} X{SUP,2} X{SUP,3} REPRESENTA - CR{SUP,2} = CR{SUP,3} CR{SUP,4} = CR{SUP,5} - (DONDE R{SUP,2}, R{SUP,3}, R{SUP,4} Y R{SUP,5} REPRESENTAN HIDROGENO Y SIMILARES) Y OTROS GRUPOS DEL MISMO TIPO; E Y REPRESENTA - CH{SUB,2}O - Y GRUPOS SIMILARES.
ES96935342T 1995-10-16 1996-10-16 Compuestos triciclicos. Expired - Lifetime ES2159047T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26723295 1995-10-16
JP32429895 1995-12-13

Publications (1)

Publication Number Publication Date
ES2159047T3 true ES2159047T3 (es) 2001-09-16

Family

ID=26547771

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96935342T Expired - Lifetime ES2159047T3 (es) 1995-10-16 1996-10-16 Compuestos triciclicos.

Country Status (12)

Country Link
US (1) US5726325A (es)
EP (1) EP0798288B1 (es)
JP (1) JP3847786B2 (es)
CN (1) CN1168133A (es)
AT (1) ATE201195T1 (es)
AU (1) AU700386B2 (es)
DE (1) DE69612835T2 (es)
ES (1) ES2159047T3 (es)
HU (1) HUP9801356A3 (es)
NO (1) NO972726L (es)
NZ (1) NZ320580A (es)
WO (1) WO1997014672A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840749A (en) * 1989-08-25 1998-11-24 Hoechst Marion Roussel, Inc. N-hydroxy-dibenz b,e!oxepinalkylamines, N-hydroxy-dibenz b,e!oxepinalkanoic acid amides and related heterocyclic analogues
AU6471896A (en) * 1995-07-24 1997-02-18 Takeda Chemical Industries Ltd. Production of optically active benzothiepin salts
KR100447674B1 (ko) * 1997-04-15 2004-09-08 교와 핫꼬 고교 가부시끼가이샤 삼환식 화합물
DE60036758T2 (de) * 1999-08-04 2008-07-24 Sumitomo Chemical Co., Ltd. Verfahren zur Herstellung von optisch aktiver 3,3,3-Trifluor-2-hydroxy-2-methylpropionsäure und deren Salze
US7354949B2 (en) 2001-03-30 2008-04-08 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for bladder irritative symptoms associated with benign prostatic hyperplasia
US7276532B2 (en) 2001-03-30 2007-10-02 Kyowa Hakko Kogyo Co., Ltd. Remedies for vesical hyperactivity
EP1384481A1 (en) * 2001-03-30 2004-01-28 Kyowa Hakko Kogyo Co., Ltd. Remedies for vesical hyperesthesia
EP1444980A1 (en) * 2001-11-13 2004-08-11 Kyowa Hakko Kogyo Co., Ltd. Preventive or remedy for pruritus
TW200400816A (en) * 2002-06-26 2004-01-16 Lilly Co Eli Tricyclic steroid hormone nuclear receptor modulators
JPWO2004087131A1 (ja) * 2003-03-31 2006-06-29 協和醗酵工業株式会社 鎮咳剤
TW200501938A (en) * 2003-06-27 2005-01-16 Kyowa Hakko Kogyo Kk A medicament for therapeutic treating overactive urinary bladder accompany with cerebrovascular disorder
WO2005007154A1 (ja) * 2003-07-16 2005-01-27 Kyowa Hakko Kogyo Co., Ltd. 疼痛の予防及び／または治療剤
JPWO2005011674A1 (ja) * 2003-08-05 2006-09-14 協和醗酵工業株式会社 気管支喘息の予防及び／または治療剤
FR2872159B1 (fr) * 2004-06-28 2007-10-05 Merck Sante Soc Par Actions Si Nouveaux derives acides carboxyliques phenyliques et leur utilisation dans le traitement du diabete
TW200606133A (en) * 2004-06-30 2006-02-16 Sankyo Co Substituted benzene compounds
DE102005022020A1 (de) * 2005-05-12 2006-11-23 Merckle Gmbh Dibenzocycloheptanverbindungen und pharmazeutische Mittel, welche diese Verbindungen enthalten
ATE524445T1 (de) * 2005-06-23 2011-09-15 Merck Sharp & Dohme Benzocycloheptapyridine als inhibitoren der tyrosinkinase met
AU2006306499A1 (en) * 2005-10-21 2007-05-03 Merck Sharp & Dohme Corp. Tyrosine kinase inhibitors
US20090291941A1 (en) * 2005-10-21 2009-11-26 Dinsmore Christopher J Tyrosine Kinase Inhibitors
EP1951047A2 (en) * 2005-10-21 2008-08-06 Merck & Co., Inc. Tyrosine kinase inhibitors
TW200813021A (en) * 2006-07-10 2008-03-16 Merck & Co Inc Tyrosine kinase inhibitors
TW200827367A (en) 2006-10-26 2008-07-01 Kyowa Hakko Kogyo Kk A therapeutic agent for irritable bowel syndrome

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458578A (en) * 1965-03-22 1969-07-29 Sandoz Ag Aminodibenzocycloalkenones
US4477465A (en) * 1983-03-10 1984-10-16 Hoechst-Roussel Pharmaceuticals Inc. Substituted 4,10-dihydro-10-oxothieno benzoxepins
JPS6310784A (ja) * 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
GB9214120D0 (en) * 1991-07-25 1992-08-12 Ici Plc Therapeutic amides

Also Published As

Publication number Publication date
DE69612835T2 (de) 2001-10-04
NO972726D0 (no) 1997-06-13
EP0798288B1 (en) 2001-05-16
HUP9801356A2 (hu) 1998-10-28
NO972726L (no) 1997-08-05
EP0798288A1 (en) 1997-10-01
US5726325A (en) 1998-03-10
MX9704411A (es) 1998-07-31
AU7332696A (en) 1997-05-07
CN1168133A (zh) 1997-12-17
WO1997014672A1 (fr) 1997-04-24
DE69612835D1 (de) 2001-06-21
JP3847786B2 (ja) 2006-11-22
AU700386B2 (en) 1999-01-07
EP0798288A4 (en) 1999-06-16
HUP9801356A3 (en) 2000-07-28
ATE201195T1 (de) 2001-06-15
NZ320580A (en) 1998-12-23

Similar Documents

Publication Publication Date Title
ES2159047T3 (es) Compuestos triciclicos.
ES2168737T3 (es) Inhibidores de la oxido nitrico sintasa.
UY24553A1 (es) Compuestos insecticidas de tipo 5- amino -4-etilsulfinil-pirazol
TR199901305T2 (xx) Calpain-�nleyicileri olarak ketonbenzamidler
ES2043625T3 (es) Derivados de acido ariloxicarboxilico, su preparacion y empleo.
AR002061A1 (es) Compuesto elastomerico que incorpora negro de carbon recubierto parcialmente, un articulo formado a partir de dicho compuesto, una formulacionque lo contiene y un metodo para mejorar la histeresis.
BR0314087A (pt) Cetoenóis spirocìclicos substituìdos
SV2003000704A (es) Inhibidores de metaloproteinasa del tipo pirimidin-2,4,6-triona pc11075/700018/bb
ES2123287T3 (es) Derivados 3-benzoil benzofuranicos como antagonistas de la hormona tiroidea.
ES8200089A1 (es) Un procedimiento para la preparacion de sales de triarilsul fonio
ES2163239T3 (es) Nuevos derivados cromenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
BR0313455A (pt) modulação "antisense" da expressão de nav1.3
WO1999003817A3 (en) Aliphatic propargylamines as cellular rescue agents
ES2149403T3 (es) Benciloxicarbonilguanidinas sustituidas como inhibidores del intercambiador de protones de sodio, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene.
ES2190471T3 (es) Procedimiento para producir derivados de guanidina, intermedios de dichos compuestos y su produccion.
ES2191062T3 (es) Derivados de pirazolil-pirazol sustituidos, procedimientos para su preparacion y su utilizacion como agentes con accion herbicida.
ES2159054T3 (es) Compuestos di-terc-butil-fenolicos que contienen azufre utiles como agentes antiinflamatorios.
ATE1624T1 (de) 6-arylpyridazin-3-one, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung.
ES2148458T3 (es) Derivados de fenil-4-tiazoles sustituidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2075941T3 (es) Procedimiento para la transformacion de los tpu por extrusion, agentes modificantes utilizados segun este procedimiento.
MX9203181A (es) Sal de mono(2-amonio-2-hidroximetil-1,3-propandiol)(2r-cis)-(3-metiloxiranil) -fosfonato y composicion farmaceutica que la contiene.
ES2179857T3 (es) Derivados de quinoleina sustituidos, procedimiento para su preparacion y su utilizacion.
AR245536A1 (es) Una composicion fotocurable
ES2157419T3 (es) Arilazadioxacicloalquenos substituidos, fungicidas.
ES2138434T3 (es) Compuesto fluoropropeno, un insecticida que lo contiene, y un compuesto intermediario para su preparacion.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 798288

Country of ref document: ES